- Home
- ICU vs APM Comparison
ICU vs APM Comparison
Compare ICU & APM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ICU | APM |
|---|---|---|
| Founded | 2018 | 2010 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.9M | 10.7M |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | ICU | APM |
|---|---|---|
| Price | $0.24 | $1.08 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 52.6K |
| Earning Date | 11-13-2025 | 12-18-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $881,000.00 | N/A |
| Revenue This Year | $691.85 | N/A |
| Revenue Next Year | $64.17 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 1195.59 | N/A |
| 52 Week Low | $0.22 | $0.69 |
| 52 Week High | $3.07 | $7.49 |
Technical Indicators
Market Signals| Indicator | ICU | APM |
|---|---|---|
| Relative Strength Index (RSI) | 31.99 | 35.90 |
| Support Level | $0.22 | $1.06 |
| Resistance Level | $0.28 | $1.23 |
| Average True Range (ATR) | 0.02 | 0.09 |
| MACD | 0.00 | -0.00 |
| Stochastic Oscillator | 10.45 | 7.78 |
Price Performance
Historical ComparisonAbout ICU SeaStar Medical Holding Corporation
SeaStar Medical Holding Corp is a medical technology company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs. It is developing and commercializing extracorporeal therapies that target the effector cells that drive systemic inflammation, causing direct tissue damage and secreting a range of pro-inflammatory cytokines that initiate and propagate imbalanced immune responses. The Company is comprised of a single reportable segment, which is its Device Segment.
About APM Aptorum Group Limited
Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in one segment: research and development. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.